CN114009722A - Lipid-lowering and stasis-removing konjac poria cocos fine powder and preparation method thereof - Google Patents
Lipid-lowering and stasis-removing konjac poria cocos fine powder and preparation method thereof Download PDFInfo
- Publication number
- CN114009722A CN114009722A CN202111270543.1A CN202111270543A CN114009722A CN 114009722 A CN114009722 A CN 114009722A CN 202111270543 A CN202111270543 A CN 202111270543A CN 114009722 A CN114009722 A CN 114009722A
- Authority
- CN
- China
- Prior art keywords
- parts
- konjak
- poria cocos
- fine powder
- stasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002752 Konjac Polymers 0.000 title claims abstract description 50
- 235000010485 konjac Nutrition 0.000 title claims abstract description 50
- 239000000843 powder Substances 0.000 title claims abstract description 35
- 244000197580 Poria cocos Species 0.000 title claims abstract description 33
- 235000008599 Poria cocos Nutrition 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 244000247812 Amorphophallus rivieri Species 0.000 title claims description 11
- 235000001206 Amorphophallus rivieri Nutrition 0.000 title claims description 11
- 239000000252 konjac Substances 0.000 title claims description 11
- 239000008280 blood Substances 0.000 claims abstract description 34
- 210000004369 blood Anatomy 0.000 claims abstract description 34
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 11
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 11
- 241000132012 Atractylodes Species 0.000 claims abstract description 11
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 11
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 11
- 241000545744 Hirudinea Species 0.000 claims abstract description 11
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 11
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 11
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 11
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 11
- 240000000249 Morus alba Species 0.000 claims abstract description 11
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 11
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 11
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 11
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 11
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 11
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 11
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 11
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- 235000008397 ginger Nutrition 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 11
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 10
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 10
- 238000000227 grinding Methods 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 claims abstract description 5
- 241000245665 Taraxacum Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 244000077995 Coix lacryma jobi Species 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims 2
- 235000013305 food Nutrition 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 208000029078 coronary artery disease Diseases 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000002159 abnormal effect Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 241000737241 Cocos Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/115—Konjak; Konntaku
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a konjak poria cocos fine powder for reducing blood fat and removing blood stasis, which comprises 30 parts of konjak, 20 parts of pearl barley, 15 parts of poria cocos, 7 parts of dried orange peel, 3 parts of dried ginger, 6 parts of soybean lecithin, 2 parts of pseudo-ginseng, 2 parts of earthworm, 2 parts of leech, 3 parts of reed rhizome, 4 parts of salvia miltiorrhiza, 5 parts of astragalus membranaceus, 7 parts of mulberry, 3 parts of codonopsis pilosula, 3 parts of bighead atractylodes rhizome, 5 parts of Chinese yam, 4 parts of medlar, 3 parts of radix rehmanniae, 3 parts of dandelion, 3 parts of semen cuscutae and 5 parts of radix ophiopogonis. The invention belongs to the technical field of konjak health products, and particularly provides konjak poria cocos fine powder which is prepared by assisting traditional Chinese medicinal materials for promoting blood circulation to remove blood stasis, tonifying kidney, nourishing liver, tonifying spleen, benefiting qi and nourishing blood, and nourishing yin and clearing heat, combining konjak, pearl barley, poria cocos and the like as auxiliary food therapy products, and obtaining extremely fine meal powder in a low-temperature grinding mode, so that stroke indexes and attack frequency and risk of coronary heart disease are effectively reduced, blood abnormal indexes of people are effectively reduced, and the effects of reducing blood fat and removing blood stasis are obvious, and a preparation method of the konjak poria cocos fine powder.
Description
Technical Field
The invention belongs to the technical field of konjak health products, and particularly relates to konjak poria cocos fine powder capable of reducing fat and removing blood stasis and a preparation method thereof.
Background
The konjak is a food with low heat energy, low protein, low vitamin and high dietary fiber, is a beneficial alkaline food, and can achieve the balance of acid and alkali for people eating too many animal acidic foods by matching with the konjak. In addition, modern medicine proves that edible konjak also has multiple functions of reducing blood sugar level, reducing blood fat, reducing blood pressure, dispelling toxin, beautifying, dredging collaterals, losing weight, relaxing bowels, stimulating appetite and the like.
However, in the prior art, it is common to use konjak as a raw material to prepare health food, but the mixing ratio of konjak and which raw material can effectively improve the function of konjak itself and enhance the effects of resisting cancer, preventing cancer and the like, still remains the direction of continuous research of technicians in the field and needs continuous research, and traditional Chinese medicine considers that liver loss, diarrhea, spleen deficiency, transportation loss and kidney qi loss are the inherent causes of hyperlipidemia. Excessive fatigue, improper diet and emotional disorder are external conditions; spleen deficiency with profuse phlegm, phlegm turbidity leading internally, damp turbidity stopping internally, old and weak, visceral qi attenuation, yang deficiency with phlegm stagnation, eventually causing phlegm accumulation and blood stasis, turning into fat turbidity, and being retained in vivo as a disease; hyperlipidemia is manifested as stagnation of turbid phlegm and blood stasis, qi and blood deficiency, and is caused by deficiency of the origin and marked excess, with the deficiency of the origin being caused by spleen, liver and kidney, and the marked excess being caused by turbid phlegm and blood stasis.
The scheme aims to provide a food therapy product capable of effectively assisting hypertension, and the aims of effectively reducing the apoplexy index and reducing the attack frequency and risk of coronary heart disease are achieved.
Disclosure of Invention
Aiming at the situation, in order to overcome the defects of the prior art, the invention provides the konjak-poria cocos refined powder which is prepared by supplementing traditional Chinese medicinal materials with the functions of promoting blood circulation to remove blood stasis, tonifying kidney, nourishing liver, strengthening spleen, tonifying qi and nourishing blood, and nourishing yin and clearing heat, combining konjak, coix seed, poria cocos and the like as auxiliary food therapy products, and grinding at low temperature to obtain extremely fine meal powder, wherein the provided tissue components are superior in quantity and quality, so that the apoplexy index is effectively reduced, the attack frequency and risk of coronary heart disease are reduced, the abnormal blood index of people is effectively reduced, and the blood fat reducing and stasis removing effects are obvious, and the preparation method of the konjak-poria cocos refined powder.
The technical scheme adopted by the invention is as follows: the invention relates to a konjak poria cocos fine powder for reducing fat and removing stasis, which comprises the following raw materials in parts by weight: 25-35 parts of konjak, 15-30 parts of pearl barley, 10-20 parts of poria cocos, 5-10 parts of dried orange peel, 2-4 parts of dried ginger, 5-7 parts of soybean lecithin, 1-3 parts of pseudo-ginseng, 1.5-2.5 parts of earthworm (traditional Chinese medicine), 1.5-2.5 parts of leech (traditional Chinese medicine), 2-3 parts of reed rhizome, 3-5 parts of salvia miltiorrhiza, 4-6 parts of astragalus membranaceus, 5-9 parts of mulberry, 2-4 parts of codonopsis pilosula, 2-4 parts of bighead atractylodes rhizome, 5-7 parts of Chinese yam, 3-5 parts of medlar, 2-4 parts of radix rehmanniae, 2-4 parts of dandelion, 2-4 parts of semen cuscutae and 4-6 parts of radix ophiopogonis.
Further, the raw materials of the konjak poria cocos fine powder for reducing blood fat and removing blood stasis comprise the following components in parts by weight: 30 parts of konjak, 20 parts of pearl barley, 15 parts of poria cocos, 7 parts of dried orange peel, 3 parts of dried ginger, 6 parts of soybean lecithin, 2 parts of pseudo-ginseng, 2 parts of earthworm, 2 parts of leech, 3 parts of reed rhizome, 4 parts of salvia miltiorrhiza, 5 parts of astragalus mongholicus, 7 parts of mulberry, 3 parts of codonopsis pilosula, 3 parts of bighead atractylodes rhizome, 5 parts of Chinese yam, 4 parts of medlar, 3 parts of radix rehmanniae, 3 parts of dandelion, 3 parts of semen cuscutae and 5 parts of radix ophiopogonis.
The invention also discloses a preparation method of the konjak poria cocos fine powder for reducing fat and removing stasis, which comprises the following steps:
the method comprises the following steps: selecting materials: selecting high-quality konjak, and crushing the konjak into konjak powder with the particle size of more than 200 meshes;
step two: selecting coix seed, poria cocos, dried orange peel, dried ginger, soybean lecithin, pseudo-ginseng, earthworm, leech, reed rhizome, salvia miltiorrhiza, astragalus membranaceus, mulberry, codonopsis pilosula, bighead atractylodes rhizome, Chinese yam, medlar, radix rehmanniae, dandelion, semen cuscutae and radix ophiopogonis according to the weight parts of the first step, mixing the components into a mixture, cleaning, and drying at the constant temperature of 80 ℃;
step three: and (5) putting the mixture obtained in the step two into a low-temperature grinding machine, adjusting the temperature to-10 ℃, grinding to more than 200 meshes, pouring into a clean container, uniformly mixing with the konjac powder to obtain the konjac poria fine powder, and drying and storing at low temperature.
Preferably, the coix seed is cooked coix seed after being fried.
The konjak poria cocos fine powder capable of reducing blood fat and removing blood stasis and the preparation method thereof have the following beneficial effects that: the product starts from the aspect of treating both symptoms and root causes, and is prepared by following the method, supplementing traditional Chinese medicinal materials for promoting blood circulation to remove blood stasis, tonifying kidney, nourishing liver, strengthening spleen, tonifying qi and nourishing blood, nourishing yin and clearing heat, combining konjak, pearl barley, poria cocos and the like as auxiliary food therapy products, and obtaining extremely fine meal powder in a low-temperature grinding mode.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments; all other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1, the raw materials of the lipid-lowering and stasis-removing konjac poria cocos fine powder comprise the following components in parts by weight: 30 parts of konjak, 20 parts of pearl barley, 15 parts of poria cocos, 7 parts of dried orange peel, 3 parts of dried ginger, 6 parts of soybean lecithin, 2 parts of pseudo-ginseng, 2 parts of earthworm, 2 parts of leech, 3 parts of reed rhizome, 4 parts of salvia miltiorrhiza, 5 parts of astragalus mongholicus, 7 parts of mulberry, 3 parts of codonopsis pilosula, 3 parts of bighead atractylodes rhizome, 5 parts of Chinese yam, 4 parts of medlar, 3 parts of radix rehmanniae, 3 parts of dandelion, 3 parts of semen cuscutae and 5 parts of radix ophiopogonis.
The preparation method of the konjak poria cocos fine powder for reducing fat and removing stasis comprises the following steps:
the method comprises the following steps: selecting materials: selecting high-quality konjak, and crushing the konjak into konjak powder with the particle size of more than 200 meshes;
step two: selecting coix seed, poria cocos, dried orange peel, dried ginger, soybean lecithin, pseudo-ginseng, earthworm, leech, reed rhizome, salvia miltiorrhiza, astragalus membranaceus, mulberry, codonopsis pilosula, bighead atractylodes rhizome, Chinese yam, medlar, radix rehmanniae, dandelion, semen cuscutae and radix ophiopogonis according to the weight parts of the first step, mixing the components into a mixture, cleaning, and drying at the constant temperature of 80 ℃;
step three: and (5) putting the mixture obtained in the step two into a low-temperature grinding machine, adjusting the temperature to-10 ℃, grinding to more than 200 meshes, pouring into a clean container, uniformly mixing with the konjac powder to obtain the konjac poria fine powder, and drying and storing at low temperature.
Example 2, the same as the preparation method of example 1, and different from example 1 only in the parts by weight of the raw materials, the lipid-lowering and blood stasis-removing konjac poria cocos fine powder in example 2 comprises the following components by weight: 25 parts of konjak, 15 parts of pearl barley, 10 parts of poria cocos, 5 parts of dried orange peel, 2 parts of dried ginger, 5 parts of soybean lecithin, 1 part of pseudo-ginseng, 1.5 parts of earthworm, 1.5 parts of leech, 2 parts of reed rhizome, 3 parts of salvia miltiorrhiza, 4 parts of astragalus membranaceus, 5 parts of mulberry, 2 parts of codonopsis pilosula, 2 parts of bighead atractylodes rhizome, 5 parts of Chinese yam, 3 parts of medlar, 2 parts of radix rehmanniae, 2 parts of dandelion, 2 parts of semen cuscutae and 4 parts of radix ophiopogonis.
Example 3, the same as the preparation method of example 1, and different from example 1 only in the parts by weight of the raw materials, the lipid-lowering and blood stasis-removing konjac poria cocos fine powder in example 3 comprises the following components by weight: 35 parts of konjak, 30 parts of pearl barley, 20 parts of poria cocos, 10 parts of dried orange peel, 4 parts of dried ginger, 7 parts of soybean lecithin, 3 parts of pseudo-ginseng, 2.5 parts of earthworm, 2.5 parts of leech, 3 parts of reed rhizome, 5 parts of salvia miltiorrhiza, 6 parts of astragalus membranaceus, 9 parts of mulberry, 4 parts of codonopsis pilosula, 4 parts of bighead atractylodes rhizome, 7 parts of Chinese yam, 5 parts of medlar, 4 parts of radix rehmanniae, 4 parts of dandelion, 4 parts of semen cuscutae and 6 parts of radix ophiopogonis.
The rhizoma Amorphophalli Poria fine powder prepared in examples 1, 2 and 3 is prepared by soaking 5-10g of rhizoma Amorphophalli Poria fine powder with 200-330mL warm boiled water at 50-80 deg.C for 5-30min before meal, and continuously taking for 14-21 days, and recording the condition.
The experimental population selects the population with the symptoms of high blood fat, high cholesterol, high blood pressure for a long time and having the attack tendency of cardiovascular and cerebrovascular diseases.
After the meal is eaten for 14-21 days before meal, the change content of blood sugar after meal of experimental population in examples 1, 2 and 3 is obviously reduced.
It should be noted that, in this document, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by the present specification, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (4)
1. The konjak poria cocos fine powder for reducing fat and removing stasis is characterized by comprising the following components in parts by weight: 25-35 parts of konjak, 15-30 parts of pearl barley, 10-20 parts of poria cocos, 5-10 parts of dried orange peel, 2-4 parts of dried ginger, 5-7 parts of soybean lecithin, 1-3 parts of pseudo-ginseng, 1.5-2.5 parts of earthworm, 1.5-2.5 parts of leech, 2-3 parts of reed rhizome, 3-5 parts of salvia miltiorrhiza, 4-6 parts of astragalus membranaceus, 5-9 parts of mulberry, 2-4 parts of codonopsis pilosula, 2-4 parts of bighead atractylodes rhizome, 5-7 parts of Chinese yam, 3-5 parts of medlar, 2-4 parts of radix rehmanniae, 2-4 parts of dandelion, 2-4 parts of semen cuscutae and 4-6 parts of radix ophiopogonis.
2. The rhizoma amorphophalli Poria cocos fine powder for reducing blood fat and removing blood stasis as claimed in claim 1, wherein: the lipid-lowering and stasis-removing konjak poria cocos fine powder comprises the following raw materials in parts by weight: 30 parts of konjak, 20 parts of pearl barley, 15 parts of poria cocos, 7 parts of dried orange peel, 3 parts of dried ginger, 6 parts of soybean lecithin, 2 parts of pseudo-ginseng, 2 parts of earthworm, 2 parts of leech, 3 parts of reed rhizome, 4 parts of salvia miltiorrhiza, 5 parts of astragalus mongholicus, 7 parts of mulberry, 3 parts of codonopsis pilosula, 3 parts of bighead atractylodes rhizome, 5 parts of Chinese yam, 4 parts of medlar, 3 parts of radix rehmanniae, 3 parts of dandelion, 3 parts of semen cuscutae and 5 parts of radix ophiopogonis.
3. The preparation method of the rhizoma amorphophalli Poria cocos fine powder with effects of reducing blood lipid and removing blood stasis as claimed in any one of claims 1-2, which is characterized by comprising the following steps:
the method comprises the following steps: selecting materials: selecting high-quality konjak, and crushing the konjak into konjak powder with the particle size of more than 200 meshes;
step two: selecting coix seed, poria cocos, dried orange peel, dried ginger, soybean lecithin, pseudo-ginseng, earthworm, leech, reed rhizome, salvia miltiorrhiza, astragalus membranaceus, mulberry, codonopsis pilosula, bighead atractylodes rhizome, Chinese yam, medlar, radix rehmanniae, dandelion, semen cuscutae and radix ophiopogonis according to the weight parts of the first step, mixing the components into a mixture, cleaning, and drying at the constant temperature of 80 ℃;
step three: and (5) putting the mixture obtained in the step two into a low-temperature grinding machine, adjusting the temperature to-10 ℃, grinding to more than 200 meshes, pouring into a clean container, uniformly mixing with the konjac powder to obtain the konjac poria fine powder, and drying and storing at low temperature.
4. The preparation method of the rhizoma Amorphophalli Poria cocos fine powder with effects of reducing blood lipid and removing blood stasis as claimed in claim 3, wherein: the coix seed is cooked coix seed after being fried.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111270543.1A CN114009722A (en) | 2021-10-29 | 2021-10-29 | Lipid-lowering and stasis-removing konjac poria cocos fine powder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111270543.1A CN114009722A (en) | 2021-10-29 | 2021-10-29 | Lipid-lowering and stasis-removing konjac poria cocos fine powder and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114009722A true CN114009722A (en) | 2022-02-08 |
Family
ID=80058604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111270543.1A Pending CN114009722A (en) | 2021-10-29 | 2021-10-29 | Lipid-lowering and stasis-removing konjac poria cocos fine powder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114009722A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129967A (en) * | 2007-08-27 | 2008-02-27 | 尹克华 | Traditional Chinese medicine for treating diabetic diarrhea |
| CN103990009A (en) * | 2013-05-23 | 2014-08-20 | 漯河医学高等专科学校 | Traditional Chinese medicine for treatment of type II diabetes by invigorating spleen and purging turbidness |
| CN104013806A (en) * | 2014-06-25 | 2014-09-03 | 石岩 | Traditional Chinese medicine composition for treating diabetes mellitus |
| CN105311593A (en) * | 2014-08-04 | 2016-02-10 | 孙茂忠 | Formulation for treating cardiac-cerebral vascular disease and stroke sequela |
| CN106692780A (en) * | 2016-12-23 | 2017-05-24 | 淄博亚大制药股份有限公司 | Composition for preventing and relieving diabetes and complications thereof |
-
2021
- 2021-10-29 CN CN202111270543.1A patent/CN114009722A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129967A (en) * | 2007-08-27 | 2008-02-27 | 尹克华 | Traditional Chinese medicine for treating diabetic diarrhea |
| CN103990009A (en) * | 2013-05-23 | 2014-08-20 | 漯河医学高等专科学校 | Traditional Chinese medicine for treatment of type II diabetes by invigorating spleen and purging turbidness |
| CN104013806A (en) * | 2014-06-25 | 2014-09-03 | 石岩 | Traditional Chinese medicine composition for treating diabetes mellitus |
| CN105311593A (en) * | 2014-08-04 | 2016-02-10 | 孙茂忠 | Formulation for treating cardiac-cerebral vascular disease and stroke sequela |
| CN106692780A (en) * | 2016-12-23 | 2017-05-24 | 淄博亚大制药股份有限公司 | Composition for preventing and relieving diabetes and complications thereof |
Non-Patent Citations (4)
| Title |
|---|
| 唐东晖: "消渴饮治疗Ⅱ型糖尿病21例疗效观察", 《新中医》 * |
| 徐好利: "补肾活血汤治疗糖尿病肾病60例", 《陕西中医》 * |
| 李金环 等: "消渴灵加减方治疗2型糖尿病临床观察", 《光明中医》 * |
| 李阳 等: "益气补肾活血方对老年2型糖尿病改善作用的观察", 《中医药临床杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102934806B (en) | Mutton sausage | |
| CN103651874A (en) | Soybean milk capable of strengthening spleen and dehumidifying and preparation method thereof | |
| CN102934815B (en) | Donkey meat sausage | |
| CN102940266A (en) | Quail sausage | |
| CN102934801A (en) | Health-care deer sausage | |
| CN103931722A (en) | Pickle and blueberry cake and preparation method therefore | |
| CN104958564A (en) | Dendrobium candidum oral liquid and preparing method thereof | |
| CN104946488A (en) | Nutritious tortoise liquor and making method thereof | |
| CN104543855A (en) | Lotus root powder capable of replenishing blood and preparation method of lotus root powder | |
| CN107028103A (en) | A kind of health care pork tripe herbal cuisine and preparation method thereof | |
| CN106616325A (en) | Haw stomach-tonifying noodles and production method of haw stomach-tonifying noodles | |
| CN108719478A (en) | A kind of preparation method of the Semen Coicis type red bean milk powder with clearing damp effect of weight reducing | |
| CN114009722A (en) | Lipid-lowering and stasis-removing konjac poria cocos fine powder and preparation method thereof | |
| CN105995586A (en) | Lotus root and donkey-hide gelatin nourishing soup and preparation method for same | |
| CN103039901B (en) | Dampness resolving and middle warmer regulating lotus root starch and preparation method | |
| CN109260287A (en) | A kind of guarantor's kidney kidney-nourishing cream is grown and preparation method thereof | |
| CN106213512B (en) | Rhizoma polygonati food suitable for diabetics to eat and preparation method thereof | |
| CN114949167A (en) | A Chinese medicinal preparation for treating weakness of spleen and stomach and abdominal distention, and its preparation method | |
| CN103039899A (en) | Lotus root starch capable of improving eyesight and preventing dizziness and preparation method thereof | |
| CN103989077A (en) | Kiwi fruit taste and flower flavor crispy rice and processing method thereof | |
| CN1107068A (en) | Jujube nourishing wine making method | |
| CN102934805A (en) | Mule meat sausage | |
| CN104186849A (en) | Fat-eliminating tea beverage | |
| CN106139134A (en) | A kind of bone and muscle strengthening health promoting wine and preparation method thereof | |
| CN108686185A (en) | A kind of skin beautifying soup and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220208 |
|
| RJ01 | Rejection of invention patent application after publication |